Actively Recruiting

Phase Not Applicable
Age: 65Years +
All Genders
ID06819982

Autonomous At Home Thanks to a Connected Device and Occupational Therapy Support

Led by Université Catholique de Louvain · Updated on 2025-02-11

3900

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to evaluate the 'Bien chez Moi 2.0' (BCM2.0) programme, which combines assistive devices with occupational therapy support to help older adults remain at home safely. The study focuses on understanding how, for whom, and why these interventions work and under what conditions. It also assesses their impact on autonomy, life goals, feelings of security, emergency hospital use, and delaying admission to nursing homes. Participants receive the BCM2.0 programme, which provides occupational therapy sessions alongside assistive devices tailored to support aging in place. The study includes multiple components such as descriptive quantitative data collection, qualitative interviews, focus groups with therapists, and a prospective cohort study following beneficiaries for up to 12 months. Additional analyses explore barriers and facilitators to implementation and ethical considerations through community meetings. During the study, participants are evaluated at enrolment and again six months later using various tools, including the Canadian Occupational Performance Measure (COPM), the Short Falls Efficacy Scale-International (FES-I), health-related quality of life assessments, and monitoring of hospitalizations and nursing home admissions. Researchers also assess the use of assistive devices, sense of security at home, and the ability to perform daily activities. The study's total follow-up duration is up to 12 months, with continued engagement through interviews and observational studies.

CONDITIONS

Brief Title

Autonomous At Home with Occupational Therapy Support and Assistive Devices

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • People aged 65 and over
  • Living at home in the Walloon and Brussels regions
  • Considered frail or at risk of frailty, defined by at least one loss of intrinsic capacity measured by a trained occupational therapist using the ICOPE screening tool
Not Eligible

You will not qualify if you...

  • People benefiting from other AViQ autonomy programmes of this project are excluded

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Up to 6 months

Participants receive occupational therapy sessions and assistive devices to support aging at home through the BCM2.0 programme.

Baseline visit and 6-month follow-up visit

Follow-up

Duration - Up to 6 months after enrolment

Participants are monitored for outcomes such as quality of life, hospitalisation, and use of assistive devices after receiving occupational therapy support.

6-month follow-up visit

Trial Site Locations

Total: 1 location

1

Ergo2.0

Yvoir, Belgium, B-5530

Actively Recruiting

Loading map...

Research Team

T

Thérèse Van Durme

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

HEALTH_SERVICES_RESEARCH

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here